This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

ISIS-1 trial

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

16027 patients entering 245 coronary care units at a mean of 5 hr after onset of the symptoms of acute myocardial infarction were randomised to:

  • atenolol:
    • 5-10 mg i.v. immediately
    • 100 mg p.o. per day for 7 days

  • standard treatment

Overall vascular mortality was significantly lower in the atenolol group at 1 yr:

  • 10.7% in the atenolol group vs. 12.0% in the control group (2p <0.01)

Immediate beta-blockade may reduce mortality in the first week post-MI by 15%.

For 200 patients treated with beta-blockers there will be:

  • 1 less death
  • 1 less arrest
  • 1 less reinfarction

Reference:

  • Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. (1986). Lancet, 2, 57-66.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.